Trade Show

CPhI Milan 2026: Meet Datwyler at Booth #11A73

Two Datwyler Experts on Stage at the World's Largest Pharma Event

  • Paolo Ferrigno presents "From Infusion to Self-Injection: The New Era of Subcutaneous Drug Delivery" on October 7 at 1:45 PM — book a meeting to go deeper on NeoFlex™ large-volume plungers and the data behind the session
  • Robert Lindner joins the panel "Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma" on October 7 at 4:15 PM — sit down with him to hear his take on where large-volume subcutaneous delivery is really heading
  • Reserve time with an expert at Booth #11A73 to explore the full portfolio, from the first-to-market 20ml NeoFlex™ plunger to ready-to-use elastomer platforms engineered for your next injectable program
Date October 06, 2026 – October 08, 2026
Location Fiera Milano | Milan, Italy
Details Booth #11A73
View Event Details
Event Overview

From Infusion to Self-Injection: Datwyler at the Center of Subcutaneous Delivery Innovation

CPHI Milan is the largest pharmaceutical ingredients and technology event on Earth — and Datwyler is bringing its full container closure and drug delivery component portfolio to this showcase, engaging manufacturers, CDMOs, and regulatory professionals from across Europe, Asia, and the Americas. 

About Our Presentations

Datwyler takes the stage twice at CPHI Milan 2026. Paolo Ferrigno presents "From Infusion to Self-Injection: The New Era of Subcutaneous Drug Delivery" on Wednesday, October 7 at 1:45 PM, and Robert Lindner joins the panel "Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma," examining device trade-offs, market adoption realities, and patient preferences for large-volume subcutaneous delivery.  

Want to connect?

Visit Booth #11A73 or book a meeting with our team to explore Datwyler's comprehensive portfolio of:

  • The first-to-market 20ml universal NeoFlex™ plunger for large-volume injectables
  • High-performance NeoFlex™ and OmniFlex® elastomer platforms for biologic drug delivery

All reflecting the full scope of modern pharmaceutical packaging needs, supported by Datwyler's Zero-Defect approach to faster development timelines and compliant manufacturing outcomes.

Featured Presentations

Presentation Details

From Infusion to Self-Injection: The New Era of Subcutaneous Drug Delivery

Date & Time October 7, 2026 • 1:45 PM
Location Packaging & Device Innovation: Hall 11 - 11A49

Paolo Ferrigno, Product Manager, Prefilled Syringes and Cartridges at Datwyler, presents "From Infusion to Self-Injection: The New Era of Subcutaneous Drug Delivery" on Wednesday, October 7 at 1:45 PM.

  • Explore how the shift from hospital IV infusion to subcutaneous self-administration is driving new challenges in drug delivery, including higher viscosity formulations, larger fill volumes, and higher expectations for system performance and reliability
  • Understand how NeoFlex™ large-volume plunger solutions support this transition by enabling safe and efficient delivery of sensitive biologics while maintaining drug stability
  • Discover how close supplier collaboration simplifies complexity, reduces development risk, and accelerates time-to-market for next-generation subcutaneous therapies
View Paolo Ferrigno
Book a Meeting with Paolo

Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma

Date & Time October 7, 2026 • 4:15 PM
Location Packaging & Device Innovation: Hall 11 - 11A49

Robert Lindner, Global Platform Leader, Biologics at Datwyler, joins the panel "Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma," moderated by Clare Beddoes, Head of Drug Delivery at Cambridge Design Partnership.

  • Comparing device trade-offs in wear time, injection duration, and patient acceptance between on-body platforms and large-format auto-injectors
  • Examining why multiple smart device solutions exist but none have achieved widespread market adoption
  • Incorporating patient group perspectives on usability, lifestyle impact, and adherence barriers for volumes exceeding 2mL

Panelists include Sara Stewart, Public Relations Communications Specialist & Patient Advocate; Soren Skov, Senior Human Factors Engineer at Roche; and Noah Flajsing, Associate Director Marketing at BD.

View Robert Lindner
Book a Meeting with Robert
Speaker Spotlight

Meet the Speakers

Paolo Ferrigno

Paolo Ferrigno

Product Manager, Prefilled Syringes & Cartridges | Datwyler
In the industry of primary parenteral packaging since 2017, Paolo Ferrigno is currently the Product Manager for PFS and cartridge components at Datwyler Healthcare. In the same company, Paolo covered different commercial and technical toles before landing back to product management in 2022. Educated in Electronics and later in Marketing, Paolo had in the past a wide range of experiences spanning from R&D for audio/electronics in the automotive and consumer markets to product management for B2B distribution of industrial and electronics components.  
View LinkedIn
Robert Lindner

Robert Lindner

Global Platform Leader, Biologics | Datwyler

Robert Lindner is the Global Platform Leader, Biologics at Datwyler, where he focuses on elastomeric closure solutions for biologic drug products. He brings over seven years of expertise in building global platforms for primary packaging containers, along with extensive experience in fill-and-finish processes, managing international R&D projects, and building global technology networks. Robert holds a PhD in Physical Chemistry from Mainz University.

View LinkedIn
Solutions Spotlight

What We're Showcasing at CPHI Milan

Explore the solutions and technologies most relevant to this event.

First-to-Market 20ml Universal Plunger for Large-Volume Injectables
Featured Solution

First-to-Market 20ml Universal Plunger for Large-Volume Injectables

Datwyler introduces the first-to-market 20ml universal NeoFlex™ plunger, engineered to support the growing demand for large-volume injectable therapies. Designed for compatibility across multiple prefilled syringe and cartridge platforms, this innovation helps simplify development, reduce qualification complexity, and support the next generation of biologic and high-dose therapies.
High-Performance Components for Biologic Drug Delivery
Featured Solution

High-Performance Components for Biologic Drug Delivery

Biologic therapies demand packaging components that deliver exceptional purity, compatibility, and performance. Datwyler's NeoFlex™ and OmniFlex® elastomer platforms are engineered to support sensitive biologic formulations, with ultra-clean manufacturing, optimized extractables profiles, and the reliability required for complex injectable drug products.
A Strategic Partner for Pharmaceutical Growth
Featured Solution

A Strategic Partner for Pharmaceutical Growth

Datwyler brings not only high-performance components, but also the global manufacturing expertise, supply reliability, and collaborative approach needed to support long-term pharmaceutical growth across markets and modalities.
Additional Information

Continue Exploring

Access additional materials and information related to this event and Datwyler’s solutions.

Resource When Size Matters: Self-Delivery Solutions for Subcutaneous Administration
→
Resource The Rise of Large-Volume Injectors in a Patient-Centric Era
→
Resource Datwyler Healthcare Product Portfolio
→
Helpful Information

faq_heading

What is CPhI Milan?
CPHI Milan is the largest pharmaceutical ingredients and technology event in the world, held annually in Milan and bringing together manufacturers, CDMOs, regulatory professionals, and innovators from across the global pharmaceutical industry.
When is CPhI Milan 2026?
CPhI Milan 2026 takes place October 6–8 at Fiera Milano in Milan, Italy.
Where can we find Datwyler at CPhI Milan?
Datwyler exhibits at Booth #11A73 at Fiera Milano.
Is Datwyler presenting at CPhI Milan?
Yes. Datwyler has two speaking slots at CPhI Milan 2026. Paolo Ferrigno, Product Manager, Prefilled Syringes and Cartridges, presents "From Infusion to Self-Injection: The New Era of Subcutaneous Drug Delivery" on October 7 at 1:45 PM. Robert Lindner, Global Platform Leader, Biologics, joins the panel "Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma."
Who is presenting for Datwyler at CPhI Milan?
Paolo Ferrigno, Product Manager, Prefilled Syringes and Cartridges, and Robert Lindner, Global Platform Leader, Biologics.
What time is Datwyler's presentation at CPhI Milan?
Paolo Ferrigno's presentation takes place on Wednesday, October 7 at 1:45 PM. Robert Lindner's panel session is October 7 at 4:15 PM.
EVENT UPDATES

Stay informed on upcoming Datwyler events

Subscribe to receive updates on conferences, presentations, and opportunities to connect with our team.